| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Research Institute of Angiocardiology, Kyushu University, Fukuoka, Japan.
1. Electrical and pharmacological properties of the low-voltage-activated Ca2+ current (ICa, LVA) in rat aorta smooth muscle cells (SMC) in primary culture were examined, particularly in comparison with the high-voltage-activated Ca2+ current (ICa, HVA). Both types of Ca2+ currents were recorded in external solution containing 20 mM-Ca2+, using the whole-cell voltage-clamp technique. 2. ICa, LVA was evoked by step depolarizations to potentials more positive than -60 mV from a holding potential of -100 mV, and reached a peak in the current-voltage (I-V) relationship around -30 mV. ICa, HVA was activated at -20 mV, and reached a peak at +20 mV. 3. The intracellular dialysis of 5 mM-F- irreversibly suppressed ICa, HVA, with time, while it has little effect on the ICa, LVA. The ICa, LVA could be separated from the ICa, HVA by either selecting the holding and test potential levels or by perfusing intracellularly with F-. 4. The ratio of peak amplitude of Ba2+, Sr2+ and Ca2+ currents in the respective I-V relationship was 1.6:1.2:1.0 for high-voltage-activated Ca2+ channels and was 1.0:1.4:1.0 for low-voltage-activated ones. 5. The inactivation phase of ICa, HVA was fitted by a sum of double-exponential functions, the time constants of which were larger when the current was carried by Ba2+ than by Ca2+. The inactivation time course of ICa, LVA was fitted by a single-exponential function, and the time constant was practically the same when the current was carried by Ba2+ or by Ca2+. Activation and inactivation processes of ICa, LVA were potential-dependent. 6. The steady-state inactivation curve of ICa, LVA was fitted by the Boltzmann equation, having a mid-potential of -80 mV and a slope factor of 5.0. The recovery time course from steady-state inactivation was fitted by a sum of two exponential functions. The time constants of the faster phase were 230 and 380 ms, and those of slower phase were 2.8 and 1.8 s at the repolarization potentials of -120 and -100 mV, respectively. 7. The amplitude of ICa, LVA depended on the external Ca2+ concentration ([Ca2+]o), approaching saturation at 95 mM [Ca2+]o. 8. Various polyvalent cations blocked both types of Ca2+ current reversibly in the order (IC50 in M): La3+ (8 x 10(-8)) greater than Cd2+ (6 x 10(-6)) greater than Ni2+ (1 x 10(-5)) greater than Zn2+ (2 x 10(-5)) for ICa, HVA, and La3+ (6 x 10(-7)) greater than Zn2+ (3 x 10(-5)) greater than Cd2+ (4 x 10(-4)) greater than Ni2+ (6 x 10(-4)) for ICa, LVA.(ABSTRACT TRUNCATED AT 400 WORDS)
This article has been cited by other articles:
|
|
 |
|
  D. M. Rodman, K. Reese, J. Harral, B. Fouty, S. Wu, J. West, M. Hoedt-Miller, Y. Tada, K.-X. Li, C. Cool, et al. Low-Voltage-Activated (T-Type) Calcium Channels Control Proliferation of Human Pulmonary Artery Myocytes Circ. Res., April 29, 2005; 96(8): 864 - 872. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. I. Brueggemann, B. L. Martin, J. Barakat, K. L. Byron, and L. L. Cribbs Low voltage-activated calcium channels in vascular smooth muscle: T-type channels and AVP-stimulated calcium spiking Am J Physiol Heart Circ Physiol, February 1, 2005; 288(2): H923 - H935. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.-G. Feng, M. Li, and L. G. Navar T-type calcium channels in the regulation of afferent and efferent arterioles in rats Am J Physiol Renal Physiol, February 1, 2004; 286(2): F331 - F337. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Cohen-Barak, Z. Yi, N. Hagiwara, K. Monzen, I. Komuro, and M. H. Brilliant Sox6 regulation of cardiac myocyte development Nucleic Acids Res., October 15, 2003; 31(20): 5941 - 5948. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Perez-Reyes Molecular Physiology of Low-Voltage-Activated T-type Calcium Channels Physiol Rev, January 1, 2003; 83(1): 117 - 161. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Yamazaki, H. Ohguro, T. Maeda, I. Maruyama, Y. Takano, T. Metoki, M. Nakazawa, H. Sawada, and M. Dezawa Preservation of Retinal Morphology and Functions in Royal College Surgeons Rat by Nilvadipine, a Ca2+ Antagonist Invest. Ophthalmol. Vis. Sci., April 1, 2002; 43(4): 919 - 926. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. P. Kumar, S. C. Stotz, R. Paramashivappa, A. M. Beedle, G. W. Zamponi, and A. S. Rao Synthesis and Evaluation of a New Class of Nifedipine Analogs with T-Type Calcium Channel Blocking Activity Mol. Pharmacol., March 1, 2002; 61(3): 649 - 658. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. L. Cribbs Vascular Smooth Muscle Calcium Channels: Could "T" Be a Target? Circ. Res., September 28, 2001; 89(7): 560 - 562. [Full Text] [PDF]
|
|
|
|
|
|
J. Satin and L. L. Cribbs Identification of a T-Type Ca2+ Channel Isoform in Murine Atrial Myocytes (AT-1 Cells) Circ. Res., March 31, 2000; 86(6): 636 - 642. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. Yeoman, B. L. Brezden, and P. R. Benjamin LVA and HVA Ca2+ Currents in Ventricular Muscle Cells of the Lymnaea Heart J Neurophysiol, November 1, 1999; 82(5): 2428 - 2440. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Morita, H. Cousins, H. Onoue, Y. Ito, and R. Inoue Predominant Distribution of Nifedipine-Insensitive, High Voltage-Activated Ca2+ Channels in the Terminal Mesenteric Artery of Guinea Pig Circ. Res., October 1, 1999; 85(7): 596 - 605. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Evans and C. H. Gelband A Novel Ca2+ Channel in Vascular Smooth Muscle? Circ. Res., October 1, 1999; 85(7): 651 - 652. [Full Text] [PDF]
|
|
|
|
 |
|
 C. Arnoult, I. G. Kazam, P. E. Visconti, G. S. Kopf, M. Villaz, and H. M. Florman Control of the low voltage-activated calcium channel of mouse sperm by egg ZP3 and by membrane hyperpolarization during capacitation PNAS, June 8, 1999; 96(12): 6757 - 6762. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Arnoult, M. Villaz, and H. M. Florman Pharmacological Properties of the T-Type Ca2+ Current of Mouse Spermatogenic Cells Mol. Pharmacol., June 1, 1998; 53(6): 1104 - 1111. [Abstract] [Full Text]
|
|
|
|
 |
|
 W. H. Frishman Mibefradil: A New Selective T-Channel Calcium Antagonist for Hypertension and Angina Pectoris Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 1997; 2(4): 321 - 330. [Abstract] [PDF]
|
|
|
|
|
|
T. Kuga, S. Kobayashi, Y. Hirakawa, H. Kanaide, and A. Takeshita Cell Cycle-Dependent Expression of L- and T-Type Ca2+ Currents in Rat Aortic Smooth Muscle Cells in Primary Culture Circ. Res., July 1, 1996; 79(1): 14 - 19. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. C. Stotz and G. W. Zamponi Identification of Inactivation Determinants in the Domain IIS6 Region of High Voltage-activated Calcium Channels J. Biol. Chem., August 24, 2001; 276(35): 33001 - 33010. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Rodriguez-Contreras, W. Nonner, and E. N. Yamoah Ca2+ transport properties and determinants of anomalous mole fraction effects of single voltage-gated Ca2+ channels in hair cells from bullfrog saccule J. Physiol., February 1, 2002; 538(3): 729 - 745. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
